Results 221 to 230 of about 461,819 (327)

Psychological well‐being and quality of life in pediatric patients with inflammatory bowel disease in clinical remission

open access: yesJPGN Reports, EarlyView.
Abstract Objectives Pediatric inflammatory bowel disease (IBD) presents significant psychological challenges, including anxiety and depression. This study investigates the prevalence of depression and anxiety symptoms in pediatric IBD patients in remission and examines the correlation between patient and parental assessments of these symptoms.
David L. Suskind   +8 more
wiley   +1 more source

Patient and healthcare professional perspectives on fatigue assessment in pediatric inflammatory bowel disease

open access: yesJPGN Reports, EarlyView.
Abstract Pediatric patients with active and quiescent inflammatory bowel disease (IBD) have known fatigue, but there is limited understanding of how fatigue is clinically assessed. This study explored perspectives of pediatric IBD patients and healthcare professionals (HCPs) regarding fatigue assessments. A multidisciplinary team, including two patient
Jennie G. David   +5 more
wiley   +1 more source

Exploring gastroprotective effect and mechanisms of epigallocatechin gallate‐impregnated black garlic in acidic ethanol‐induced gastric ulcer model mice

open access: yesJournal of the Science of Food and Agriculture, EarlyView.
Abstract Background Peptic ulcers, particularly gastric ulcers (GUs), are multifactorial disorders with unclear mechanisms. Black garlic (BG) has shown gastroprotective effects. This study evaluated the effects of BG and epigallocatechin gallate‐impregnated BG (EG) in acidic ethanol (AE)‐induced GU model mice. Mice were pretreated with BG or EG (50–200 
Ming‐Shiun Tsai   +7 more
wiley   +1 more source

Astragaloside IV Alleviates Ulcerative Colitis Progression by Inhibiting WDR5‐Mediated ENO1 H3K4me3 Modification

open access: yesThe Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT Ulcerative colitis (UC) has become a prevalent global health concern. This study scrutinized the influence of Astragaloside IV (ASI) on DSS‐induced UC, with particular emphasis on the role of WDR5 in mediating ENO1 expression. The therapeutic efficacy of ASI was assessed in a mouse model of UC by evaluating disease activity index, pathology ...
Su‐Xiao Wu   +3 more
wiley   +1 more source

Vedolizumab as induction and maintenance therapy for ulcerative colitis.

open access: yesNew England Journal of Medicine, 2013
B. Feagan   +15 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy